Life Science Research

PET and MR Metabolic Imaging Techniques

Investigating metabolism from different angles for a fuller picture

Metabolic Imaging Techniques

Positron emission tomography (PET) is currently the gold standard in clinical and preclinical metabolic imaging owing in part to the sensitivity and quantitative metrics of PET. Metabolic PET most commonly uses the glucose analogue tracer [18F]FDG, however a range of sugar and lipid tracers are also used in research.

Metabolic magnetic resonance (MR) of brain, organs and skeletal muscle can be obtained by proton (1H) magnetic resonance spectroscopy (MRS),  magnetic resonance spectroscopic imaging (MRSI), non-proton (X-nuclei) MRS and MRSI, as well as chemical exchange saturation transfer (CEST) imaging. While most of these methods do not require contrast agents, some require administration of labeled compounds. 

PET, Broad Utility in Metabolic Studies

PET is a well-established tool in research for interrogating metabolism. This is owing to the high molecular sensitivity of PET and broad utility especially using the metabolic PET tracer [18F]FDG. [18F]FDG falls in the class of tracers known as metabolic trap tracers. Due to the unique biochemical properties of [18F]FDG, the tracer is transported into cells by glucose transport proteins and trapped inside the cells. [18F]FDG -PET is used widely in oncology, neurology, and broader tissues. Owing to the shift in tumor metabolism known as the Warburg effect, [18F]FDG can be used broadly in cancer imaging. Changes in brain metabolism are observed in a range of neurodegenerative conditions. PET metabolic studies in disease models of metabolic syndrome, diabetes, and therapies are also widely reported. For example, peripheral disease processes associated with metabolic syndrome may employ metabolic PET for early detection of metabolic disease.



[18F]FDG-PET/MR in Metabolic Imaging:
(Left) Mouse brain [18F]FDG-PET/MRI in study of neurodegenerative disease. Mouse brain axial view, MR reference only, and orthogonal views with VOI atlas placement. (Center) [18F]FDG-PET/MRI in an orthotopic osteosarcoma tumor model reveals heterogenous tumor micro-environment. (Right) [18F]FDG-PET/MRI study of metabolic disease effects in peripheral mouse muscle. Muscle fibers (blue arrow), bone/joint (green arrow), and vasculature (white arrows) are noted.
Courtesy of Prof. M Wang, Fralin Biomedical Research Institute, Virginia Tech Carilion, Roanoke, VA, USA

Hyperpolarized MRI: Supercharging Metabolic Substrates

In recent years, preclinical research using hyperpolarized 13C substrates has gained increasing popularity. Though the effect is transient, hyperpolarization increases the MR signal (>10,000-fold) by increasing spin polarization. The most widely used technique for the hyperpolarization of 13C substrates is dynamic nuclear polarization. It is combined with rapid dissolution to generate solutions that can be injected into organisms. 

Hyperpolarized 13C MRI has been used to assess a variety of metabolic pathways and to characterize their dynamic properties in vivo. Among them, 13C pyruvate, an endogenous molecule, is the most widely studied hyperpolarized probe given its role in multiple metabolic pathways, including glycolysis, the tricarboxylic acid cycle (e.g., 13C αketoglutarate, 13C succinate, and 13C fumarate), and amino acid biosynthesis. It has also been exploited to characterize metabolic alterations in preclinical models of cardiovascular and neurological disorders. Moreover, multiple studies have shown the utility of using hyperpolarized 13C pyruvate to measure the Warburg effect in cancer models. Beyond hyperpolarized 13C pyruvate, hyperpolarized probes can inform on global tissue properties such as pH balance or cellular oxidative potential.




Hyperpolarized MRI in study of metabolic differences in patient derived (PDX) renal cell carcinoma (RCC) models:
Mice implanted with PDX tissue in the renal capsule were examined using 2D EPSI at 3T after infusion of hyperpolarized [1-13C] pyruvate. Spectroscopic imaging allowed temporal tracking of both pyruvate as well as lactate in different locations of the tumor.
Courtesy: R. Sriram, S. Subramaniam, D. Peehl, J. Kurhanewicz et al, Pre-Clinical MR Imaging Core, University of California, San Francisco, CA, USA

More Information

New Molecular MRI Agent

An interview with Franz Schilling and Martin Grashei on Hyperpolarized 13C-labelled Z-OMPD

Beyond Proton Imaging: X-nuclei

Sodium (23Na) MRI, & Metabolic Homeostasis

Sodium (Na+) is the second most abundant cation in the body and plays a crucial role in osmoregulation and physiology of cells. They affect the energy-consuming processes of membrane transport and neurotransmission, and act as a counter ion for balancing charges of tissue anionic macromolecules. Thus, 23Na MRI has been used to non-invasively detect endogenous sodium ion concentrations in the brain, cartilage, and body, for example, to study 23Na content changes in skeletal muscle during exercise, myocardial ion homeostasis, and kidney function evaluation.

There is a large Na+ concentration gradient in tissue between the intracellular and the extracellular space, maintained primarily by energy-dependent Na+/K+-ATPase. If the cell membrane is destroyed or energy metabolism disturbed, it can drive an impairment of the Na+/K+-ATPase, which exacerbates intracellular sodium concentration and induces cell malfunction eventually leading to cell death. 23Na MRI has been used to study pathological changes in Na+ tissue concentration in preclinical models of brain tumors, stroke, and other neurological disorders. As an altered Na+/K+-ATPase activity promotes cancer metastasis by mediating invasion and migration, 23Na MRI has been used to monitor Na+ changes during tumor growth and metastasis and to assess the effect of anticancer therapy.

Carbon (13C) MRS/MRSI, & Organic Metabolic Substrates

Carbon (13C) MRS and MRSI detect and map resonances from 13C, the only stable isotope of carbon having a magnetic moment. The fact that the natural abundance for 13C is approximately 1.1% of total carbon and its gyromagnetic ratio is approximately one-fourth of that of the proton, renders 13C MRS a relatively insensitive technique. Sensitivity can be noticeably improved by using isotopically enriched 13C substrates. The detection of substrates selectively enriched with 13C in specific carbon positions has made it possible to follow a large variety of metabolic pathways, including glycolysis, the pentose phosphate pathway, glycogen synthesis and degradation, gluconeogenesis, the Krebs cycle, ketogenesis, and ureogenesis, among others. The combined use of 13C substrates with MRS and MRSI has been established as an alternative to PET techniques as it provides chemical information in addition to the spatial information of labeled compounds.

Phosphorus (31P) MRS/MRSI for Mitochondrial ATP & Beyond

The phosphorus 31P isotope has a natural abundance of 100% in the body. Measuring levels of 31P containing metabolites including phosphocreatine (PCr), beta-nucleoside triphosphate (β-NTP), phosphomonoesters (PME), phosphodiester (PDE) and inorganic phosphate (Pi) by 31P MRS and MRSI allows monitoring of bioenergetic processes, membrane phospholipids metabolism, and tissue pH in the intact organism. By assessing the frequency shift of the β-adenosine triphosphate (ATP) peak, the concentration of magnesium, which is important for nerve transmission and neuromuscular function, can be measured in tissue. In addition, 31P magnetization transfer experiments permit the estimation of the unidirectional fluxes associated with metabolic exchange reactions and have been used to examine the bioenergetic reactions of the creatine-kinase system and the ATP synthesis/hydrolysis cycle. Preclinical applications of these techniques in organs including the brain, skeletal muscle, liver, and heart under physiological and pathological conditions have been demonstrated. Measurement of tissue pH with 31P MRS has been used in preclinical cancer studies as tumor acidity is an important hallmark of the disease.






31P-CSI Mitochondrial ATP in rat heart. 1H FLASH localizer and 31P-CSI of rat heart acquired within 1 hour using 12% compressed sensing on BioSpec 70/20 with a 31P TR 25 mm surface coil.

Deuterium (2H) Metabolic Spectroscopy/Imaging (DMS)/(DMI)

Deuterium (2H) is a stable hydrogen isotope with a favorable T1 and SNR potential. Although it has an extremely low natural abundance (0.0156%), DMS and DMI can be used to study cellular energy metabolism via the uptake, breakdown, and downstream processing of glucose after infusion of 2H-labeled glucose. 

During glycolysis, glucose is converted to pyruvate which can enter the Krebs cycle, where its metabolic breakdown leads to efficient production of adenosine triphosphate (ATP) via oxidative phosphorylation. The glycolysis and Krebs cycle intermediates, e.g., glutamate/glutamine, lactate, and water can then be detected based on their well-resolved 2H resonances and chemical shifts. The analysis and kinetic modeling of time-resolved DMS and DMI experiments enable the calculation of glycolytic rate and Krebs cycle rate. The methods provide excellent sensitivity and temporal resolution for detection and have been proven to be technically simple and robust. 

DMS and DMI have been applied for investigations of energy metabolism in the brain, heart, and liver. Moreover, disease conditions that are associated with an altered energy metabolism can be studied. For example, when there is lack of oxygen during ischemia, glycolysis is anaerobic, and pyruvate is converted into lactate instead of entering the Krebs cycle. In addition, it is known that tumor cells have an increased glucose demand and rely, even under oxygen-sufficient conditions, mainly on aerobic glycolysis for energy production, leading to an increased lactate production in tumors. 




Deuterium Metabolic Imaging of fatty liver disease:
High fat versus standard liver metabolism are compared in rats. Rainbow intensity scale bar shows relative metabolic activity overlayed on liver. Courtesy: V. Ehret, U. Ustsinau, T. Scherer, C. Fürnsinn, C. Philippe, M. Krššák, Medical University of Vienna, Vienna, Austria

More Information

Elton Tadeu Montrazi, Weizmann Institute of Science, Israel

Chemical Exchange Saturation Transfer (CEST)

In chemical exchange saturation transfer (CEST), endogenous molecules with slowly exchanging groups such as amine (-NH2), amide (-NH), or hydroxyl (-OH) that possess a chemical shift, which is distinct from water are selectively saturated and the saturation is transferred to the bulk water via chemical exchange. Since these chemical groups can be found in proteins, peptides, and amino acids in biological tissue, CEST allows in vivo mapping of several metabolites and molecules in the body. The indirect detection of less concentrated protons through the observation of those that are highly concentrated makes CEST imaging a high sensitivity technique with good spatial resolution. By optimizing saturation parameters of the radiofrequency pulse (e.g. saturation intensity, offset, and duration), it is possible to probe different exchanging protons. 

In the brain, CEST has been used to detect metabolites such as glutamate, glucose, creatine, and myo-inositol which are involved in energy metabolism and neurotransmission. These molecules have also been explored in preclinical models as imaging biomarkers of neurological diseases in which metabolic pathways are altered. CEST is also an important imaging tool in cancer research as tumors are characterized by increased glucose metabolism and peptide production, with glutamate, creatine, and lactate being important metabolites. Moreover, CEST has also been applied to other body parts such as the heart and skeletal muscle during health and disease.



CEST insights into metabolic tumor processes:
Study in C3H/Tif tumor mice undergoing proton beam therapy. Clear differences in CEST images with amide, amine, and aliphatic-NOE weighting.
Courtesy: K. Kalita, K. Jasiński, and W. Węglarz, Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland and B. Sørensen, Aarhus University, Aarhus, Denmark

Webinars

csm_bruker_webinar_f8fcaed196
February 16, 2017

Metabolic Imaging in Neurodegenerative Disease using CEST MRI

This webinar will emphasize the significance of CEST in studying neurodegenerative diseases such as Alzheimer's and Huntington's diseases, conditions and also spinal cord disorders.
csm_banner-webinar-11-october_084db73c7b
December 14, 2017

New insights into brain function

In this webinar, MR physicist Professor Seong-Gi Kim and market product manager Tim Wokrina from Bruker BioSpin will discuss how CEST imaging significantly benefits from ultra-high fields.
banner-webinar-2-may-2019
May 2, 2019

Rapid, Quantitative CEST Imaging with MRI Fingerprinting

CEST is a relatively new MRI technique that indirectly measures the rate of exchange between protons on a target molecule and the surrounding
CEST MRI: Practical considerations and useful applications
On Demand Session

CEST MRI: Practical considerations and useful applications

Marty Pagel provides recommendations for a successful CEST experiment, including taking animal motion and physiology stability into account, as well as tips for respiratory gating, optimization of saturation times and powers, and number of frequency values.
Quantification and application of CEST signals in rodent brain
On Demand Session

Quantification and application of CEST signals in rodent brain

Dr. Zhang then elaborates on his contributions to these goals using his BioSpec 11.7 T, focusing on CEST quantification, which he uses for early stroke detection and in combination with pH guided surgeries.
csm_webinar-24-september-2020_2b162c54c1
September 24, 2020

Introduction to CEST for MRI Assessment of Brain Ischemia and Cancer Lesions

Chemical exchange saturation transfer (CEST) is a type of contrast mechanism that is becoming increasingly popular in the field of magnetic resonance
CEST MRI: Practical considerations and useful applications
On Demand Session

Imaging Alzheimer’s disease using CEST MRI

Alzheimer’s disease (AD) is the most common type of dementia, and is a multifactorial neurodegenerative disease.
CEST Atlanta

Chemical Exchange Saturation Transfer (CEST) imaging Expert Series

We welcome you to an exclusive webinar series with experts from around the world. Kannie Chan, Steffen Goerke, Mike McMahon, and Daisy Villano met virtually to discuss the facets of CEST that they each will present, so that their talks perfectly complement each other.
When Instruments Drive Science: From single neuron diffusion fMRI to GlucoCEST fMRI at 17T
On Demand Session

When Instruments Drive Science: From single neuron diffusion fMRI to GlucoCEST fMRI at 17T

Prof. Denis Le Bihan has played a substantial role in the initiation and development of diffusion imaging in MRI. In his talk, he takes us on an historical tour of diffusion imaging, explaining how he performs diffusion-based fMRI, and culminating with his most recent discoveries using GlucoCEST fMRI.